Selected News from Today's FirstWord
GlaxoSmithKline says executives may have violated Chinese law
GlaxoSmithKline said Monday that some of its senior executives may have violated Chinese law, after four were detained by authorities earlier this month amid claims the drugmaker was involved in Full story
- Biogen Idec investigating death of patient who took MS drug Tecfidera - (Ref. CNBC; Morningstar; The Wall Street Journal; StreetInsider)
- GlaxoSmithKline suspends scheme to boost stake in Nigerian unit - (Ref. GlaxoSmithKline; Interactive Investor; NASDAQ; StockMarketWire; 4-traders; Financial Times)
- Wockhardt shares tumble after receiving FDA warning letter - (Ref. Moneycontrol.com; The Economic Times; livemint.com; Business Standard; Business Line)
- Chinese authorities question AstraZeneca employee as industry probe widens - (Ref. Fidelity; The Telegraph; International Business Times; Bloomberg; The Wall Street Journal)
Also in the News
- Products:
- Kyprolis,
- paclitaxel,
- PUR0200,
- Stivarga,
- Tecfidera,
- trastuzumab,
- vemurafenib
- Markets:
- United Kingdom,
- United States,
- World
FirstWord Dossier Reports
www.fwreports.com
**NEW** The complete list of FirstWord Dossier reports can be found at www.fwreports.com
FirstWord Dossier reports provide insight, analysis and the latest thinking on important trends and the most challenging issues affecting the pharmaceutical industry today. Highly-focused, relevant, up-to-date and actionable intelligence ... reports that deliver information vital for competitive advantage.Click here to see our recent reports.
Most Read Stories in the Past Week
Recent Reports
- Building Strong Market Access Teams
- Biosimilars Regulatory Update: an evolving landscape
- Pharma Social Media Campaigns: current thinking and future outlook
- Pharma Market Insights: Closed Loop Marketing
- Pharma Sales Force Innovations: technology, training and rewards
- Pharma YouTube Channels: Content and Comment (Nexus Report)
- The Medical Device Outlook in Emerging Markets - (FirstShelf)
- The Hepatitis Market Outlook to 2015 - (FirstShelf)
- Digital Doctors: Marketing to Online Networks
- Generic Substitution: Taking a Narrow View?
- Closing the Loop: Beyond Digital Detailing
- Pharma Marketing in Latin America
- Biosimilars: Surveying the Market Landscape